| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2025-11-05 |
Evommune
Life Science Palo Alto, California www.evommune.com Evommune is a biopharmaceutical company developing innovative therapies in the area of chronic inflammation, particularly in dermatological conditions. Evommune was founded in 2020 and is based in Palo Alto, California. |
IPO | - |
Andera Partners
EQT Life Sciences
|
||
| 2025-06-09 |
Caris Life Sciences
Life Science Irving, Texas www.carislifesciences.com Caris Life Sciences is a biosciences company focused on developing and delivering innovative molecular diagnostic, prognostic and theranostic services. As an innovative biotechnology company, Caris is actively working to fulfill the promise of precision medicine through transformative platforms to help patients with cancer and other complex diseases. Caris Life Sciences was founded in 2008 and is based in Irving, Texas. |
IPO | - |
J.H. Whitney Capital Partners
Silver Lake
|
||
| 2025-03-21 |
Visen Pharma
Life Science Shanghai, China www.visenpharma.com Visen Pharma is a biopharmaceutical company focused on endocrine-related treatments. It is committed to providing more humane and innovative therapies to enable endocrine patients to enjoy better treatment processes and efficacy, achieving their desired lives. Visen Pharma was founded in 2018 and is based in Shanghai, China. |
IPO | - |
Vivo Capital
HBM Partners
Ascendis Pharma
|
||
| 2024-12-18 |
Sai Life
Life Science Hyderabad, India www.sailife.com Sai Life is an integrated provider of drug discovery, development, and manufacturing solutions for innovator pharmaceutical and biotechnology companies. The company’s ongoing commitment to quality, thorough approach, and state-of-the-art research and manufacturing facilities enable its highly skilled team of professionals to provide its clients with competitive advantages such as shorter time to market and risk minimization. Sai Life was founded in 1999 and is based in Hyderabad, Telangana. |
IPO | - |
TPG
HBM Partners
|
||
| 2024-08-06 |
Akums
Life Science Delhi, India www.akums.in Akums is a manufacturing pharmaceutical company. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. Akums was founded in 2004 and is based in Delhi, Haryana. |
IPO | - |
Quadria Capital
|
||
| 2023-08-18 |
Concord Biotech
Life Science Ahmedabad, India www.concordbiotech.com Concord Biotech is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. Concord Biotech was founded in 2000 and is based in Ahmedabad, India. |
IPO | - |
Quadria Capital
|
||
| 2023-05-09 |
Mankind Pharma
Life Science New Delhi City, India www.mankindpharma.com Mankind Pharma is a pharmaceutical company by number of prescriptions, and is 5th in the market by domestic sales. Mankind produces branded generic drugs sold throughout India, with a uniquely deep reach in rural and semi-urban markets. Mankind Pharma was founded in 1995 and is based in New Delhi, Haryana. |
IPO | - |
Capital Group Private Markets
HarbourVest Partners
|
||
| 2023-03-17 |
LakeShore Bio
Life Science Beijing, China www.lakeshorebio.com LakeShore Bio is a biopharmaceutical company, researches, develops, manufactures, and markets immuno-oncology products and vaccines. LakeShore Bio was founded in 1994 and is based in Beijing, China |
IPO | - |
Eight Roads
|
||
| 2023-02-09 |
Mineralys
Life Science Radnor, Pennsylvania www.mineralystx.com Mineralys is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that the company is initially developing for the treatment of patients with uncontrolled hypertension. Mineralys was founded in 2019 and is based in Radnor, Pennsylvania. |
IPO | - |
Adams Street Partners
Andera Partners
HBM Partners
|
||
| 2022-11-15 |
Acrivon
Life Science Watertown, Massachusetts www.acrivon.com Acrivon is a proprietary, streamlined approach to develop patient selection tumor biopsy tests, called OncoSignature tests. Company’s lead molecule ACR-368 is a potent, selective inhibitor of CHK1 and CHK2 which has shown deep durable single agent activity, including complete responses, in a proportion of patients across several Phase 2 studies of platinum-resistant ovarian cancer and in squamous cell cancers, including anal cancer for which FDA has granted orphan drug designation. Acrivon was founded in 2018 and is based in Watertown, Massachusetts. |
IPO | - |
HBM Partners
|
||
| 2022-09-19 |
Third Harmonic Bio
Life Science San Francisco, California www.thirdharmonicbio.com Third Harmonic Bio is a clinical stage bio technology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders. Third Harmonic Bio was founded in 2019 and is based in San Francisco, California. |
IPO | - |
General Atlantic
|
||
| 2022-05-18 |
Prenetics
Life Science Hong Kong, China www.prenetics.com Prenetics is a major global diagnostic and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars Prevention, Diagnostics and Personalized Care comprehensive and accessible to anyone, at any time and anywhere. Prenetics was founded in 2014 and is based in Hong Kong, China. |
IPO | - |
Apis Partners
|
||
| 2022-04-12 |
Hinova Pharmaceuticals
Life Science Chengdu, China www.hinovapharma.com Hinova Pharmaceuticals engages in the development and production of drugs in the therapeutic areas of tumors and metabolic diseases. It develops drugs based on technology platforms, such as deuterium and PROTAC. Hinova Pharmaceuticals was founded in 2013 and is based in Chengdu, China. |
IPO | - |
Hermed Capital Co. Ltd.
|
||
| 2021-12-10 |
CANbridge
Life Science Suzhou, China www.canbridgepharma.com CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China. CANbridge was founded in 2012 and is based in Suzhou, China. |
IPO | - |
General Atlantic
WuXi AppTec
|
||
| 2021-11-05 |
IO Biotech
Life Science Copenhagen, Denmark www.iobiotech.com IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. IO Biotech's pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech was founded in 2014 and is based in Copenhagen, Denmark. |
IPO | - |
HBM Partners
Vivo Capital
Idinvest Partners
|
||
| 2021-11-01 |
Compass Therapeutics
Life Science Boston, United Kingdom www.compasstherapeutics.com Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain-based multispecific platforms to empirically identify multispecific and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. Compass Therapeutics was incorporated in 2014 and is based in Boston, Massachusetts. |
IPO | - |
Eight Roads
|
||
| Avg |
$32
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
